The binding of CD38 antibodies to various hematologic tumor cell lines (Raji, Daudi, L-1236, NCI-H929, Reh, and MOLM-13) in vitro was assessed via flow cytometry. Here, CD38 is linked to hematopoietic and lymphoid cell neoplasm.